BioCryst Pharmaceuticals, Inc. (BCRX) M&A Call Transcript

Core Viewpoint - BioCryst Pharmaceuticals is discussing its proposed acquisition of Astria Therapeutics during a conference call [2]. Group 1 - The conference call includes participation from key executives: CEO Jon Stonehouse, President and Chief Commercial Officer Charlie Gayer, and Chief Financial Officer Babar Ghias [2]. - A press release and slide presentation regarding the acquisition are available on the Investor Relations website [3]. - The call will contain forward-looking statements related to the proposed transaction, including financial estimates and expected timing [3].